Reddy B S
Division of Nutritional Carcinogenesis, American Health Foundation, Valhalla, New York, USA.
IARC Sci Publ. 1996(139):221-35.
The concept of chemoprevention of cancer by micronutrients is based upon evidence from human epidemiology and from studies of animal carcinogenesis models for cancer-inhibiting potential of certain minerals and vitamins. These micronutrients are diverse with respect to chemical structures and physiological effects, and include calcium, selenium, carotenoids, and vitamins A, C, D and E. The dietary intake of various micronutrients has been observed to alter significantly the incidence and mortality of a variety of human cancers including those of the oesophagus, stomach, colon, breast and cervix. Studies of laboratory animal models have also provided relevant mechanistic and efficacy data on the role of specific micronutrients as well as minor non-nutrients of dietary origin in the carcinogenic process. Micronutrients and such minor non-nutrients have been found to modulate the formation and bioactivation of carcinogens, modify the promotion and progression of carcinogenesis, alter cellular and host defences, and affect cellular differentiation-ultimately leading to variations in tumour incidences. Our understanding of biochemical and biological mechanisms of carcinogenesis and of inhibition of initiation, promotion and progression by particular micronutrients-both naturally occurring forms and their synthetic analogues-has made it possible to develop strategies for clinical intervention by these agents. It is possible that intervention with individual micronutrients and minor non-nutrients, and/or with a combination of such compounds with different modes of action, will prevent, delay or reverse the process of carcinogenesis and thus reduce the incidence of and mortality due to human cancers. A number of Phase II clinical trials have been initiated with the objective of identifying and evaluating intermediate biomarkers that will be used as surrogate end points for cancer. Several surrogate end points have been standardized and validated for their specificity. The results are very encouraging.
微量营养素对癌症进行化学预防的概念基于人类流行病学证据以及对某些矿物质和维生素抑制癌症潜力的动物致癌模型研究。这些微量营养素在化学结构和生理效应方面各不相同,包括钙、硒、类胡萝卜素以及维生素A、C、D和E。据观察,各种微量营养素的饮食摄入量会显著改变多种人类癌症的发病率和死亡率,包括食管癌、胃癌、结肠癌、乳腺癌和宫颈癌。对实验动物模型的研究也提供了有关特定微量营养素以及饮食来源的少量非营养物质在致癌过程中作用的相关机制和功效数据。已发现微量营养素和此类少量非营养物质可调节致癌物的形成和生物活化、改变致癌作用的促进和进展、改变细胞和宿主防御,并影响细胞分化,最终导致肿瘤发病率的变化。我们对致癌作用的生化和生物学机制以及特定微量营养素(天然存在形式及其合成类似物)对起始、促进和进展的抑制作用的理解,使得开发这些物质的临床干预策略成为可能。单独使用微量营养素和少量非营养物质,和/或使用具有不同作用方式的此类化合物组合进行干预,有可能预防、延缓或逆转致癌过程,从而降低人类癌症的发病率和死亡率。已经启动了一些II期临床试验,目的是识别和评估将用作癌症替代终点的中间生物标志物。一些替代终点已针对其特异性进行了标准化和验证。结果非常令人鼓舞。